Source: Simply Better Brands Corp.
  • Simply Better Brands (SBBC) is upsizing its private placement
  • The company will issue up to 580,046 units for gross proceeds of up to $2.5M
  • The offering is expected to close on or about February 18, 2022
  • The net proceeds of the offering will be used to repay debt
  • Simply Better Brands leads an international omni-channel platform with diversified assets in the plant-based and holistic wellness consumer product categories
  • Shares of Simply Better Brands Corp. (SBBC) opened trading at C$4.88

Simply Better Brands (SBBC) has upsized its previously announced private placement to $2.5M. The company will issue up to 580,046 units at a price of $4.31 per unit.

Each unit will consist of one common share and one-half of one share purchase warrant. Each whole warrant will entitle the holder to purchase one additional share at a price of $5.06 for up to two years following the closing date of the offering.

The net proceeds of the offering will be used to repay debt.

The completion of the offering will be subject to acceptance by the TSX Venture Exchange.

The offering is expected to close on or about February 18, 2022.

All units issued will be subject to a four-month hold period.

Simply Better Brands leads an international omnichannel platform with diversified assets in the plant-based and holistic wellness consumer product categories.

Shares of Simply Better Brands Corp. (SBBC) opened trading at C$4.88.

More From The Market Online

“Paw Patrol” owners see a 52-week share price high

Spin Master (TSX:TOY) reported 8.9 per cent revenue growth to US$436.4 million and returned to profitability.

Uber Eats expands grocery delivery network with new U.S. regional retail partners

Uber (NYSE:UBER) Eats added Busch’s Fresh Food Market, Hays, and Lowe’s Market to its grocery delivery marketplace across the U.S.

Cybersecurity stocks worth watching as digital risks continue to evolve

Cybersecurity threats continue to evolve, while recent disruptions highlighted the importance of resilient digital infrastructure.

A small-cap contender looking to challenge the weight-loss drug giants

Structure Therapeutics (NASDAQ:GPCR) is developing an oral weight-loss pill that could offer an alternative to popular injectable treatments.